Immune Function and Recurrent Pregnancy Loss

Seminars in Reproductive Medicine

Volumn 33, Issue 4, 2015, Pages 305-311

  Krieg, Sacha ^a   Westphal, Lynn ^b  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

immune tolerance; implantation; inflammation; recurrent pregnancy loss

Indexed keywords

ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; DECIDUA; HUMAN; IMMUNITY; IMMUNOCOMPETENT CELL; INFLAMMATION; INNATE IMMUNITY; NIDATION; NONHUMAN; RECURRENT DISEASE; RECURRENT PREGNANCY LOSS; SPONTANEOUS ABORTION; TROPHOBLAST; ABORTION, HABITUAL; FEMALE; IMMUNE SYSTEM; IMMUNOLOGY; PREGNANCY; UTERUS;

ABORTION, HABITUAL; EMBRYO IMPLANTATION; FEMALE; HUMANS; IMMUNE SYSTEM; PREGNANCY; UTERUS;

EID: 84934277910     PISSN: 15268004     EISSN: 15264564     Source Type: Journal    
DOI: 10.1055/s-0035-1554917     Document Type: Article

References (94)

1. Boklage C. E. Survival probability of human conceptions from fertilization to term. Int J Fertil: 1990; 35 2 75, 79-80, 81-94
2. Wilcox A. J., Weinberg C. R., O'Connor J. F., et al. Incidence of early loss of pregnancy. N Engl J Med: 1988; 319 4 189 194
3. Practice Committee of American Society for Reproductive Medicine Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertil Steril: 2013; 99 1 63
4. Practice Committee of the American Society for Reproductive Medicine Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril: 2012; 98 5 1103 1111
5. McQueen D. B., Bernardi L. A., Stephenson M. D. Chronic endometritis in women with recurrent early pregnancy loss and/or fetal demise. Fertil Steril: 2014; 101 4 1026 1030
6. Liddell H. S., Pattison N. S., Zanderigo A. Recurrent miscarriage-outcome after supportive care in early pregnancy. Aust N Z J Obstet Gynaecol: 1991; 31 4 320 322
7. Musters A. M., Taminiau-Bloem E. F., van den Boogaard E., van der Veen F., Goddijn M. Supportive care for women with unexplained recurrent miscarriage: patients' perspectives. Hum Reprod: 2011; 26 4 873 877
8. Whitley K. A., Ural S. H. Treatment modalities in recurrent miscarriages without diagnosis. Semin Reprod Med: 2014; 32 4 319 322
9. Singh M., Chaudhry P., Asselin E. Bridging endometrial receptivity and implantation: network of hormones, cytokines, and growth factors. J Endocrinol: 2011; 210 1 5 14
10. Lockwood C. J., Krikun G., Rahman M., Caze R., Buchwalder L., Schatz F. The role of decidualization in regulating endometrial hemostasis during the menstrual cycle, gestation, and in pathological states. Semin Thromb Hemost: 2007; 33 1 111 117
11. Lessey B. A., Young S. L. Homeostasis imbalance in the endometrium of women with implantation defects: the role of estrogen and progesterone. Semin Reprod Med: 2014; 32 5 365 375
12. Nikas G., Aghajanova L. Endometrial pinopodes: some more understanding on human implantation? Reprod Biomed Online: 2002; 4 03 18 23
13. Someya M., Kojima T., Ogawa M., et al. Regulation of tight junctions by sex hormones in normal human endometrial epithelial cells and uterus cancer cell line Sawano. Cell Tissue Res: 2013; 354 2 481 494
14. Murphy C. R., Rogers P. A., Hosie M. J., Leeton J., Beaton L. Tight junctions of human uterine epithelial cells change during the menstrual cycle: a morphometric study. Acta Anat (Basel): 1992; 144 1 36 38
15. Teles A., Zenclussen A. C. How cells of the immune system prepare the endometrium for implantation. Semin Reprod Med: 2014; 32 5 358 364
16. Haller-Kikkatalo K., Altmäe S., Tagoma A., Uibo R., Salumets A. Autoimmune activation toward embryo implantation is rare in immune-privileged human endometrium. Semin Reprod Med: 2014; 32 5 376 384
17. Park D. W., Yang K. M. Hormonal regulation of uterine chemokines and immune cells. Clin Exp Reprod Med: 2011; 38 4 179 185
18. Straub R. H. The complex role of estrogens in inflammation. Endocr Rev: 2007; 28 5 521 574
19. Olsen N. J., Kovacs W. J. Gonadal steroids and immunity. Endocr Rev: 1996; 17 4 369 384
20. Kim J. J., Taylor H. S., Lu Z., et al. Altered expression of HOXA10 in endometriosis: potential role in decidualization. Mol Hum Reprod: 2007; 13 5 323 332
21. Taylor H. S., Bagot C., Kardana A., Olive D., Arici A. HOX gene expression is altered in the endometrium of women with endometriosis. Hum Reprod: 1999; 14 5 1328 1331
22. Lessey B. A., Castelbaum A. J., Sawin S. W., et al. Aberrant integrin expression in the endometrium of women with endometriosis. J Clin Endocrinol Metab: 1994; 79 2 643 649
23. Calleja-Agius J., Jauniaux E., Pizzey A. R., Muttukrishna S. Investigation of systemic inflammatory response in first trimester pregnancy failure. Hum Reprod: 2012; 27 2 349 357
24. Calleja-Agius J., Jauniaux E., Muttukrishna S. Placental villous expression of TNF α and IL-10 and effect of oxygen tension in euploid early pregnancy failure. Am J Reprod Immunol: 2012; 67 6 515 525
25. Christiansen O. B. Reproductive immunology. Mol Immunol: 2013; 55 1 8 15
26. Bansal A. S. Joining the immunological dots in recurrent miscarriage. Am J Reprod Immunol: 2010; 64 5 307 315
27. Seshadri S., Sunkara S. K. Natural killer cells in female infertility and recurrent miscarriage: a systematic review and meta-analysis. Hum Reprod Update: 2014; 20 3 429 438
28. Park D. W., Lee H. J., Park C. W., Hong S. R., Kwak-Kim J., Yang K. M. Peripheral blood NK cells reflect changes in decidual NK cells in women with recurrent miscarriages. Am J Reprod Immunol: 2010; 63 2 173 180
29. Thum M. Y., Bhaskaran S., Abdalla H. I., et al. An increase in the absolute count of CD56dimCD16+CD69+ NK cells in the peripheral blood is associated with a poorer IVF treatment and pregnancy outcome. Hum Reprod: 2004; 19 10 2395 2400
30. Polgar K., Hill J. A. Identification of the white blood cell populations responsible for Th1 immunity to trophoblast and the timing of the response in women with recurrent pregnancy loss. Gynecol Obstet Invest: 2002; 53 1 59 64
31. Wilkens J., Male V., Ghazal P., et al. Uterine NK cells regulate endometrial bleeding in women and are suppressed by the progesterone receptor modulator asoprisnil. J Immunol: 2013; 191 5 2226 2235
32. Jensen F., Woudwyk M., Teles A., et al. Estradiol and progesterone regulate the migration of mast cells from the periphery to the uterus and induce their maturation and degranulation. PLoS ONE: 2010; 5 12 e14409
33. Woidacki K., Jensen F., Zenclussen A. C. Mast cells as novel mediators of reproductive processes. Front Immunol: 2013; 4 29
34. Woidacki K., Popovic M., Metz M., et al. Mast cells rescue implantation defects caused by c-kit deficiency. Cell Death Dis: 2013; 4 e462
35. Drudy L., Sheppard B., Bonnar J. Mast cells in the normal uterus and in dysfunctional uterine bleeding. Eur J Obstet Gynecol Reprod Biol: 1991; 39 3 193 201
36. Eidukaite A., Tamosiunas V. Endometrial and peritoneal macrophages: expression of activation and adhesion molecules. Am J Reprod Immunol: 2004; 52 2 113 117
37. Tachi C., Tachi S. Macrophages and implantation. Ann N Y Acad Sci: 1986; 476 158 182
38. Miller L., Hunt J. S. Sex steroid hormones and macrophage function. Life Sci: 1996; 59 1 1 14
39. Houser B. L., Tilburgs T., Hill J., Nicotra M. L., Strominger J. L. Two unique human decidual macrophage populations. J Immunol: 2011; 186 4 2633 2642
40. Lin Y. J., Lai M. D., Lei H. Y., Wing L. Y. Neutrophils and macrophages promote angiogenesis in the early stage of endometriosis in a mouse model. Endocrinology: 2006; 147 3 1278 1286
41. Strzemienski P. J., Dyer R. M., Kenney R. M. Effect of estradiol and progesterone on antistaphylococcal activity of neutrophils from ovariectomized mares. Am J Vet Res: 1987; 48 11 1638 1641
42. Strzemienski P. J., Dyer R. M., Sertich P. L., Garcia M. C., Kenney R. M. Bactericidal activity of peripheral blood neutrophils during the oestrous cycle and early pregnancy in the mare. J Reprod Fertil: 1987; 80 1 289 293
43. Wiesenfeld H. C., Heine R. P., Krohn M. A., et al. Association between elevated neutrophil defensin levels and endometritis. J Infect Dis: 2002; 186 6 792 797
44. Amsalem H., Kwan M., Hazan A., et al. Identification of a novel neutrophil population: proangiogenic granulocytes in second-trimester human decidua. J Immunol: 2014; 193 6 3070 3079
45. Kasius J. C., Fatemi H. M., Bourgain C., et al. The impact of chronic endometritis on reproductive outcome. Fertil Steril: 2011; 96 6 1451 1456
46. Alijotas-Reig J., Llurba E., Gris J. M. Potentiating maternal immune tolerance in pregnancy: a new challenging role for regulatory T cells. Placenta: 2014; 35 4 241 248
47. La Rocca C., Carbone F., Longobardi S., Matarese G. The immunology of pregnancy: regulatory T cells control maternal immune tolerance toward the fetus. Immunol Lett: 2014; 162 (1, Pt A): 41 48
48. Tilburgs T., Scherjon S. A., van der Mast B. J., et al. Fetal-maternal HLA-C mismatch is associated with decidual T cell activation and induction of functional T regulatory cells. J Reprod Immunol: 2009; 82 2 148 157
49. Würfel W. Treatment with granulocyte colony-stimulating factor in patients with repetitive implantation failures and/or recurrent spontaneous abortions. J Reprod Immunol: 2015; 108 123 135
50. Rahmati M., Petitbarat M., Dubanchet S., Bensussan A., Chaouat G., Ledee N. Granulocyte-Colony Stimulating Factor related pathways tested on an endometrial ex-vivo model. PLoS ONE: 2014; 9 9 e102286
51. Bansal R. R., Mackay C. R., Moser B., Eberl M. IL-21 enhances the potential of human γδ T cells to provide B-cell help. Eur J Immunol: 2012; 42 1 110 119
52. Szekeres-Bartho J., Barakonyi A., Miko E., Polgar B., Palkovics T. The role of gamma/delta T cells in the feto-maternal relationship. Semin Immunol: 2001; 13 4 229 233
53. Mincheva-Nilsson L. Pregnancy and gamma/delta T cells: taking on the hard questions. Reprod Biol Endocrinol: 2003; 1 120
54. Krieg S. A., Fan X., Hong Y., et al. Global alteration in gene expression profiles of deciduas from women with idiopathic recurrent pregnancy loss. Mol Hum Reprod: 2012; 18 9 442 450
55. Wang W. J., Liu F. J., Qu H. M., et al. Regulation of the expression of Th17 cells and regulatory T cells by IL-27 in patients with unexplained early recurrent miscarriage. J Reprod Immunol: 2013; 99 1-2 39 45
56. Bansal A. S., Bajardeen B., Thum M. Y. The basis and value of currently used immunomodulatory therapies in recurrent miscarriage. J Reprod Immunol: 2012; 93 1 41 51
57. Szereday L., Miko E., Meggyes M., et al. Commitment of decidual haematopoietic progenitor cells in first trimester pregnancy. Am J Reprod Immunol: 2012; 67 1 9 16
58. Saifi B., Rezaee S. A., Tajik N., et al. Th17 cells and related cytokines in unexplained recurrent spontaneous miscarriage at the implantation window. Reprod Biomed Online: 2014; 29 4 481 489
59. Stuart L. M., Takahashi K., Shi L., Savill J., Ezekowitz R. A. Mannose-binding lectin-deficient mice display defective apoptotic cell clearance but no autoimmune phenotype. J Immunol: 2005; 174 6 3220 3226
60. Ogden C. A., deCathelineau A., Hoffmann P. R., et al. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med: 2001; 194 6 781 795
61. Kilpatrick D. C., Bevan B. H., Liston W. A. Association between mannan binding protein deficiency and recurrent miscarriage. Hum Reprod: 1995; 10 9 2501 2505
62. Christiansen O. B., Nielsen H. S., Lund M., Steffensen R., Varming K. Mannose-binding lectin-2 genotypes and recurrent late pregnancy losses. Hum Reprod: 2009; 24 2 291 299
63. Hiby S. E., Apps R., Sharkey A. M., et al. Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2. J Clin Invest: 2010; 120 11 4102 4110
64. Christiansen O. B., Kolte A. M., Dahl M., et al. Maternal homozygocity for a 14 base pair insertion in exon 8 of the HLA-G gene and carriage of HLA class II alleles restricting HY immunity predispose to unexplained secondary recurrent miscarriage and low birth weight in children born to these patients. Hum Immunol: 2012; 73 7 699 705
65. Moffett A., Hiby S. E., Sharkey A. M. The role of the maternal immune system in the regulation of human birthweight. Philos Trans R Soc Lond B Biol Sci: 2015; 370 1663 20140071
66. Christiansen O. B., Steffensen R., Nielsen H. S. The impact of anti-HY responses on outcome in current and subsequent pregnancies of patients with recurrent pregnancy losses. J Reprod Immunol: 2010; 85 1 9 14
67. Nielsen H. S., Witvliet M. D., Steffensen R., et al. The presence of HLA-antibodies in recurrent miscarriage patients is associated with a reduced chance of a live birth. J Reprod Immunol: 2010; 87 1-2 67 73
68. Christiansen O. B., Steffensen R., Nielsen H. S., Varming K. Multifactorial etiology of recurrent miscarriage and its scientific and clinical implications. Gynecol Obstet Invest: 2008; 66 4 257 267
69. Ticconi C., Rotondi F., Veglia M., et al. Antinuclear autoantibodies in women with recurrent pregnancy loss. Am J Reprod Immunol: 2010; 64 6 384 392
70. Meroni P. L., Borghi M. O., Raschi E., Tedesco F. Pathogenesis of antiphospholipid syndrome: understanding the antibodies. Nat Rev Rheumatol: 2011; 7 6 330 339
71. Qureshi F., Yang Y., Jaques S. M., et al. Anti-DNA antibodies cross-reacting with laminin inhibit trophoblast attachment and migration: implications for recurrent pregnancy loss in SLE patients. Am J Reprod Immunol: 2000; 44 3 136 142
72. Petri M., Allbritton J. Fetal outcome of lupus pregnancy: a retrospective case-control study of the Hopkins Lupus Cohort. J Rheumatol: 1993; 20 4 650 656
73. Hardy C. J., Palmer B. P., Morton S. J., Muir K. R., Powell R. J. Pregnancy outcome and family size in systemic lupus erythematosus: a case-control study. Rheumatology (Oxford): 1999; 38 6 559 563
74. Naganuma M., Kunisaki R., Yoshimura N., et al. Conception and pregnancy outcome in women with inflammatory bowel disease: A multicentre study from Japan. J Crohn's Colitis: 2011; 5 4 317 323
75. Miyakis S., Lockshin M. D., Atsumi T., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost: 2006; 4 2 295 306
76. Ernest J. M., Marshburn P. B., Kutteh W. H. Obstetric antiphospholipid syndrome: an update on pathophysiology and management. Semin Reprod Med: 2011; 29 6 522 539
77. Committee on Practice Bulletins-Obstetrics, American College of Obstetricians and Gynecologists Practice Bulletin No. 132: Antiphospholipid syndrome. Obstet Gynecol: 2012; 120 6 1514 1521
78. de Jesus G. R., Agmon-Levin N., Andrade C. A., et al. 14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome. Autoimmun Rev: 2014; 13 8 795 813
79. Di Simone N., Meroni P. L., de Papa N., et al. Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I. Arthritis Rheum: 2000; 43 1 140 150
80. Meroni P. L., et al. Human beta2-GPI binds to trophoblast through its fifth domain affecting human chorionic gonadotrophin release. Arthritis Rheum: 2000; 43 9 S306 S306
81. Di Simone N., Di Nicuolo F., D'Ippolito S., et al. Antiphospholipid antibodies affect human endometrial angiogenesis. Biol Reprod: 2010; 83 2 212 219
82. Stagnaro-Green A., Roman S. H., Cobin R. H., el-Harazy E., Alvarez-Marfany M., Davies T. F. Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies. JAMA: 1990; 264 11 1422 1425
83. Smith M. L., Schust D. J. Endocrinology and recurrent early pregnancy loss. Semin Reprod Med: 2011; 29 6 482 490
84. Imaizumi M., Pritsker A., Kita M., Ahmad L., Unger P., Davies T. Pregnancy and murine thyroiditis: thyroglobulin immunization leads to fetal loss in specific allogeneic pregnancies. Endocrinology: 2001; 142 2 823 829
85. Imaizumi M., Pritsker A., Kita M., Ahmad L., Unger P., Davies T. F. Non-MHC driven exacerbation of experimental thyroiditis in the postpartum period. Autoimmunity: 2001; 34 2 95 105
86. Iijima T., Tada H., Hidaka Y., Mitsuda N., Murata Y., Amino N. Effects of autoantibodies on the course of pregnancy and fetal growth. Obstet Gynecol: 1997; 90 3 364 369
87. Kutteh W. H., Schoolcraft W. B., Scott R. T. Jr. Antithyroid antibodies do not affect pregnancy outcome in women undergoing assisted reproduction. Hum Reprod: 1999; 14 11 2886 2890
88. Kutteh W. H., Yetman D. L., Carr A. C., Beck L. A., Scott R. T. Jr. Increased prevalence of antithyroid antibodies identified in women with recurrent pregnancy loss but not in women undergoing assisted reproduction. Fertil Steril: 1999; 71 5 843 848
89. Negro R., Formoso G., Mangieri T., Pezzarossa A., Dazzi D., Hassan H. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metab: 2006; 91 7 2587 2591
90. Glinoer D. Thyroid immunity, thyroid dysfunction, and the risk of miscarriage: à propos article by Vaquero et al. Mild thyroid abnormalities and recurrent spontaneous abortion: diagnostic and therapeutical approach. Am J Reprod Immunol: 2000; 43 4 202 203
91. Krassas G. E., Poppe K., Glinoer D. Thyroid function and human reproductive health. Endocr Rev: 2010; 31 5 702 755
92. Reid S. M., Middleton P., Cossich M. C., Crowther C. A. Interventions for clinical and subclinical hypothyroidism in pregnancy. Cochrane Database Syst Rev: 2010; 7 CD007752
93. Pengo V., Tripodi A., Reber G., et al. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. Update of the guidelines for lupus anticoagulant detection. J Thromb Haemost: 2009; 7 10 1737 1740
94. Prins J. R., Kieffer T. E., Scherjon S. A. Immunomodulators to treat recurrent miscarriage. Eur J Obstet Gynecol Reprod Biol: 2014; 181 334 337